Amant F - Search Results

1

Progesterone receptor gene variants and risk of endometrial cancer.

O'Mara TA, Fahey P, Ferguson K, Marquart L, Lambrechts D, Despierre E, Vergote I, Amant F, Hall P, Liu J, Czene K; SASBAC; Rebbeck TR; WISE Study Group; AOCS Management Group; SEARCH; Ahmed S, Dunning AM, Gregory CS, Shah M; ANECS; Webb PM, Spurdle AB. O'Mara TA, et al. Among authors: amant f. Carcinogenesis. 2011 Mar;32(3):331-5. doi: 10.1093/carcin/bgq263. Epub 2010 Dec 10. Carcinogenesis. 2011. PMID: 21148628 Free PMC article.

2

Incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy.

Vergote I, De Smet I, Amant F. Vergote I, et al. Among authors: amant f. Gynecol Oncol. 2002 Mar;84(3):537-8. doi: 10.1006/gyno.2001.6422. Gynecol Oncol. 2002. PMID: 11855893 No abstract available.

3

PTEN mutation analysis in uterine leiomyosarcomas and mixed mullerian sarcomas.

Amant F, Vergote I. Amant F, et al. Am J Obstet Gynecol. 2002 Jul;187(1):258. doi: 10.1067/mob.2002.124942. Am J Obstet Gynecol. 2002. PMID: 12114928 No abstract available.

4

Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literature.

Amant F, Moerman P, Cadron I, Hagemeijer A, Vergote I, Debiec-Rychter M. Amant F, et al. Gynecol Oncol. 2003 Mar;88(3):459-62. doi: 10.1016/s0090-8258(02)00096-3. Gynecol Oncol. 2003. PMID: 12648605 Review.

5

Immunohistochemical determination of hormone receptors in uterine adenosarcomas.

Amant F, Gabriel C, Moerman P, Vergote I. Amant F, et al. Gynecol Oncol. 2003 Mar;88(3):463-4. doi: 10.1016/s0090-8258(02)00006-9. Gynecol Oncol. 2003. PMID: 12648606 No abstract available.

6

Bifunctional pathway of uterine carcinosarcomas.

Amant F, Vergote I. Amant F, et al. Hum Pathol. 2003 Mar;34(3):299; author reply 300. doi: 10.1053/hupa.2003.20. Hum Pathol. 2003. PMID: 12673570 No abstract available.

7

The diagnostic problem of endometrial stromal sarcoma: report on six cases.

Amant F, Moerman P, Cadron I, Neven P, Berteloot P, Vergote I. Amant F, et al. Gynecol Oncol. 2003 Jul;90(1):37-43. doi: 10.1016/s0090-8258(03)00207-5. Gynecol Oncol. 2003. PMID: 12821339 Review.

8

A possible role of the cytochrome P450c17alpha gene (CYP17) polymorphism in the pathobiology of uterine leiomyomas from black South African women: a pilot study.

Amant F, Dorfling CM, de Brabanter J, Vandewalle J, Vergote I, Lindeque BG, van Rensburg EJ. Amant F, et al. Acta Obstet Gynecol Scand. 2004 Mar;83(3):234-9. Acta Obstet Gynecol Scand. 2004. PMID: 14995917

9

Importance of the endometrioid carcinoma subtype and sarcomatous component in uterine carcinosarcoma.

Amant F, Vergote I. Amant F, et al. Gynecol Oncol. 2004 Apr;93(1):272-3; author reply 273-4. doi: 10.1016/j.ygyno.2004.01.015. Gynecol Oncol. 2004. PMID: 15047252 No abstract available.

10

Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma.

Amant F, Schurmans K, Steenkiste E, Verbist L, Abeler VM, Tulunay G, De Jonge E, Massuger L, Moerman P, Vergote I. Amant F, et al. Gynecol Oncol. 2004 Jun;93(3):680-5. doi: 10.1016/j.ygyno.2004.03.021. Gynecol Oncol. 2004. PMID: 15196864

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

576 results

Search Page